ALK and neuroblastoma: Consistently, in NPM-ALK+ ALCL [13], as in EML4-ALK lung cancers [94] and ALK-mutated neuroblastoma [95,96], a synergistic activity of ALK and mTOR inhibition had been described, although the authors did not investigate the involvement of autophagy associated with cell death in these settings.